A Double-blind, Randomized, Placebo-controlled, Crossover Study to Evaluate the Effects of JNJ-39439335 (a TRPV1 Antagonist) in Healthy Male Adult Subjects on the Paradoxical Pain Induced by a Thermal Grill.
Phase of Trial: Phase I
Latest Information Update: 01 Jul 2010
At a glance
- Drugs Mavatrep (Primary)
- Indications Pain
- Focus Therapeutic Use
- 01 Jul 2010 Actual end date (June 2010) added as reported by ClinicalTrials.gov.
- 01 Jul 2010 Actual number of patients added to 12 as reported by ClinicalTrials.gov.
- 01 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.